• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

纳米雄黄肾毒性的代谢组学研究

余霞霞, 李少元, 华云飞, 吕艺伟, 张墨翰, 黄寅

余霞霞, 李少元, 华云飞, 吕艺伟, 张墨翰, 黄寅. 纳米雄黄肾毒性的代谢组学研究[J]. 中国药科大学学报, 2017, 48(3): 328-333. DOI: 10.11665/j.issn.1000-5048.20170313
引用本文: 余霞霞, 李少元, 华云飞, 吕艺伟, 张墨翰, 黄寅. 纳米雄黄肾毒性的代谢组学研究[J]. 中国药科大学学报, 2017, 48(3): 328-333. DOI: 10.11665/j.issn.1000-5048.20170313
YU Xiaxia, LI Shaoyuan, HUA Yunfei, LYU Yiwei, ZHANG Mohan, HUANG Yin. Metabolic profiling of the nephrotoxicity of realgar nanoparticles in rats[J]. Journal of China Pharmaceutical University, 2017, 48(3): 328-333. DOI: 10.11665/j.issn.1000-5048.20170313
Citation: YU Xiaxia, LI Shaoyuan, HUA Yunfei, LYU Yiwei, ZHANG Mohan, HUANG Yin. Metabolic profiling of the nephrotoxicity of realgar nanoparticles in rats[J]. Journal of China Pharmaceutical University, 2017, 48(3): 328-333. DOI: 10.11665/j.issn.1000-5048.20170313

纳米雄黄肾毒性的代谢组学研究

基金项目: 国家自然科学基金资助项目(No.81403181);江苏省自然科学基金资助项目(No.BK20140664)

Metabolic profiling of the nephrotoxicity of realgar nanoparticles in rats

  • 摘要: 采用色谱-质谱联用的代谢组学方法分析纳米雄黄对大鼠肾脏中内源性小分子代谢物的影响,研究代谢物谱变化与肾毒性之间的关联性,为纳米雄黄毒性机制的深入研究、纳米雄黄药物的临床应用提供依据。将SD大鼠随机分为溶媒对照组、雄黄低中高剂量组和纳米雄黄低中高剂量组(40,200,1 000 mg/kg)共7组,连续灌胃28 d后处死大鼠,收集血清和肾脏样本。经血生化和组织病理学检查,证实纳米雄黄可导致肾脏损伤,且受损程度呈剂量依赖性。同时采用LC-MS和GC-MS对肾脏中代谢物变化进行整体表征,利用模式识别进行数据挖掘,发现高剂量纳米雄黄组大鼠肾脏样本中半胱氨酸、蛋氨酸、脯氨酸及LysoPE、LysoPC等32个代谢物含量较对照组均发生明显改变,提示上述代谢物与纳米雄黄肾毒性相关,为潜在毒性标志物。代谢通路分析结果表明,纳米雄黄对肾脏的毒性机制可能与氨基酸和脂质代谢等有关。
    Abstract: The effect of realgar nanoparticles(NPs)on endogenous small molecules in rat kidney was analyzed by mass spectrometry-based metabolomics. The relationship between the changes of metabolites and the nephrotoxicity of realgar NPs was also discussed to provide a basis for the further toxicity study and the clinical application of realgar NPs. SD rats were randomly divided into seven groups, including control group, three doses(40, 200, 1 000 mg/kg)of relegar and realgar NPs groups, respectly. After 28 days of continuous intragastric administration, all rats were sacrificed and their serum and kidney samples were collected. The toxic effect of realgar NPs on kidney tissues were examined by biochemical analysis and histopathologic examination, which revealed a dose-dependent nephrotoxicity induced by realgar NPs. The LC-MS and GC-MS analysis were performed for the subsequent metabolomics study. A series of 32 metabolites were found to be altered significantly in the kindey of realgar NPs treated rats, and might serve as potential nephrotoxicity biomarkers. The results of metabolic pathway analysis indicated that the nephrotoxicity of realgar NPs might be associated with the disorders of the amino acids and phosphatidic acid metabolism.
  • [1] Huang Y,Tian Y,Li G,et al.Discovery of safety biomarkers for realgar in rat urine using UFLC-IT-TOF/MS and 1H NMR based metabolomics[J].Anal Bioanal Chem,2013,405(14):4811-4822.
    [2] Dong J,Wu J,Wang MY,et al.Progress in toxicology of realgar and its compound prescription[J].Clin J Pharmacol Toxicol(中国药理学和毒理学杂志),2011,25(6):601-603.
    [3] Wang XB,Gao HY,Hou BL,et al.Nanoparticle realgar powders induce apoptosis in U937 cells through caspase MAPK and mitochondrial pathways[J].Arch Pharm Res,2007,30(5):653-658.
    [4] Tian Y,Wang X,Xi R,et al.Enhanced antitumor activity of realgar mediated by milling it to nanosize[J].Int J Nanomedicine,2014,9(1):745-757.
    [5] Liu K,Zhang LH,Xu RR,et al.Progress and mechanism of realgar in blood disorder[J].J Liaoning Univ TCM(辽宁中医药大学学报),2014,16(1):199-201.
    [6] Shi D,Liu Y,Xi R,et al.Caveolin-1 contributes to realgar nano-particle therapy in human chronic myelogenous leukemia K562 cells[J].Int J Nanomedicine,2016,11:5823-5835.
    [7] Zhang P,Chen J,Wang Y,et al.Discovery of potential biomarkers with dose- and time-dependence in cisplatin-induced nephrotoxicity using metabolomics integrated with a principal component-based area calculation strategy[J].Chem Res Toxicol,2016,29(5):776-783.
    [8] Rahman A,Ahmed S,Vasenwala SM,et al.Glyceryl trinitrate,a nitric oxide donor,abrogates ferric nitrilotriacetate-induced oxidative stress and renal damage[J].Arch Biochem Biophys,2003,418(1):71-79.
    [9] Maldonado PD,Barrera D,Rivero I,et al.Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage[J].Free Radic Biol Med,2003,35(3):317-324.
    [10] Galhardi CM, Diniz YS, Faine LA, et al. Toxicity of copper intake:lipid profile,oxidative stress and susceptibility to renal dysfunction[J].Food Chem Toxicol,2004,42(12):2053-2060.
    [11] Kitchin KT, Ahmad S. Oxidative stress as a possible mode of action for arsenic carcinogenesis [J].Toxicol Lett,2003,137(1):3-13.
    [12] Passagne I,Morille M,Rousset M,et al.Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells[J].Toxicology,2012,299(2/3):112-124.
    [13] Mili'c M,Leitinger G,Paviˇc i'c I,et al.Cellular uptake and toxicity effects of silver nanoparticles in mammalian kidney cells[J].J Appl Toxicol,2014,35(6):581-592.
  • 期刊类型引用(8)

    1. 龚蕾蕾. 纳米药物递送系统治疗乳腺癌的研究进展. 医学理论与实践. 2023(06): 939-941 . 百度学术
    2. 卓新雨,张艾立,马菲,崔志磊,刘臻,谢恬. 纳米载药系统的研究进展. 广东化工. 2022(10): 85-87 . 百度学术
    3. 刘盼,王路,董能峰,刘力,李炳生. 量子点的制备及其在药物检测和药物递送领域中的应用. 广东化工. 2021(08): 152-153+151 . 百度学术
    4. 文鹏,石峰. 纳米材料在肿瘤治疗中的研究进展. 肿瘤药学. 2021(02): 153-157+164 . 百度学术
    5. 程晓昆,张越,吕海军,刘歆颖,侯森林,陈爱兵. 多孔碳纳米材料构建抗肿瘤药物靶向传递系统的研究进展. 无机材料学报. 2021(01): 9-24 . 百度学术
    6. 王小宁,闫梦茹,马远涛,梁晓燕,罗国平. 载紫杉醇聚(2-乙基-2-噁唑啉)修饰单壁碳纳米管递药系统的制备及体外抗肿瘤作用评价. 中草药. 2020(03): 607-615 . 百度学术
    7. 王鹏. 基于碳纳米线圈的细胞应激性测试探针. 云南大学学报(自然科学版). 2020(05): 941-948 . 百度学术
    8. 李学暖,李天昊,张嘉琳,黎孔月,蒋靖超,程昊. 多壁碳纳米管修饰玻碳电极电致化学发光测奈福泮. 广西科技大学学报. 2020(04): 124-131 . 百度学术

    其他类型引用(8)

计量
  • 文章访问数:  892
  • HTML全文浏览量:  0
  • PDF下载量:  2116
  • 被引次数: 16
出版历程
  • 刊出日期:  2017-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭